INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 157 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 2.78 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $124,580 | -38.6% | 11,264 | -23.3% | 0.00% | – |
| Q2 2022 | $203,000 | +9.7% | 14,691 | +29.5% | 0.00% | – |
| Q1 2022 | $185,000 | -56.2% | 11,347 | -33.7% | 0.00% | -100.0% |
| Q4 2020 | $422,000 | +46.5% | 17,104 | +146.1% | 0.00% | 0.0% |
| Q3 2020 | $288,000 | -20.2% | 6,949 | -7.7% | 0.00% | 0.0% |
| Q2 2020 | $361,000 | +8.4% | 7,526 | +178.9% | 0.00% | 0.0% |
| Q4 2019 | $333,000 | +3.4% | 2,698 | -44.3% | 0.00% | 0.0% |
| Q3 2019 | $322,000 | +24.8% | 4,842 | +107.9% | 0.00% | 0.0% |
| Q1 2019 | $258,000 | +13.2% | 2,329 | +2.7% | 0.00% | 0.0% |
| Q4 2018 | $228,000 | -60.4% | 2,268 | -4.9% | 0.00% | -50.0% |
| Q2 2015 | $576,000 | +66.0% | 2,386 | +94.3% | 0.00% | 0.0% |
| Q1 2015 | $347,000 | +57.0% | 1,228 | -13.4% | 0.00% | +100.0% |
| Q4 2014 | $221,000 | – | 1,418 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chicago Capital Management, LLC | 185,781 | $4,611,565 | 12.16% |
| Samsara BioCapital, LLC | 640,688 | $11,878,356 | 3.64% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 2,203,295 | $40,849,089 | 2.14% |
| Versor Investments LP | 378,480 | $7,017,019 | 1.42% |
| Magnetar Financial LLC | 2,407,209 | $44,629,655 | 1.14% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,077,893 | $38,524,136 | 0.85% |
| Fort Baker Capital Management LP | 430,600 | $7,983,324 | 0.74% |
| EHP Funds Inc. | 84,210 | $1,561,253 | 0.73% |
| Terrapin Asset Management, LLC | 30,000 | $556,200 | 0.63% |
| AQR Arbitrage LLC | 734,970 | $13,626,344 | 0.61% |